Reference health

Danshen (<i>Salvia miltiorrhiza</i>) restricts MD2/TLR4‐MyD88 complex formation and signalling in acute myocardial infarction‐induced heart failure

https://doi.org/10.1111/jcmm.15688
CiteStamped reference-health badge
39/39 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 39 checked references that resolve
resolves10.1038/s41569-019-0261-7
Looking back and thinking forwards — 15 years of cardiology and cardiovascular research
resolves10.1016/j.jchf.2017.09.015
Post-Myocardial Infarction Heart Failure
resolves10.1161/CIRCRESAHA.116.303577
The Biological Basis for Cardiac Repair After Myocardial Infarction
resolves10.1016/j.vph.2016.10.008
TLR signalling and association of TLR polymorphism with cardiovascular diseases
resolves10.1038/nrrheum.2016.61
Toll-like receptors and chronic inflammation in rheumatic diseases: new developments
resolves10.1016/j.jacbts.2019.01.002
Administration of a TLR9 Inhibitor Attenuates the Development and Progression of Heart Failure in Mice
resolves10.1155/2018/9874109
The Role of Toll-Like Receptor Signaling in the Progression of Heart Failure
resolves10.1038/s41467-017-01866-w
MyD88 promotes myoblast fusion in a cell-autonomous manner
resolves10.1371/journal.pone.0057348
In Vivo Knockdown of TAK1 Accelerates Bone Marrow Proliferation/Differentiation and Induces Systemic Inflammation
resolves10.2174/1381612822666161010105242
Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases
resolves10.1002/ptr.3513
Effect of<i>Salvia miltiorrhiza</i>Hydrophilic Extract on Antioxidant Enzymes in Diabetic Patients with Chronic Heart Disease: A Randomized Controlled Trial
resolves10.1002/ptr.4611
Effect of <i>Salvia miltiorrhiza</i> Hydrophilic Extract on the Endothelial Biomarkers in Diabetic Patients with Chronic Artery Disease
resolves10.1038/srep36949
Qishen granules inhibit myocardial inflammation injury through regulating arachidonic acid metabolism
resolves10.1016/j.ijcard.2019.05.063
Trimetazidine in cardiovascular medicine
resolves10.1186/s12872-017-0632-0
Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure
resolves10.1007/s11897-019-00450-1
Reappraisal of Inflammatory Biomarkers in Heart Failure
resolves10.1016/j.hlc.2019.11.013
Prognostic Value of Lactate Dehydrogenase for Mid-Term Mortality in Acute Decompensated Heart Failure: A Comparison to Established Biomarkers and Brain Natriuretic Peptide
resolves10.1016/j.jep.2017.04.027
Danshen injection prevents heart failure by attenuating post-infarct remodeling
resolves10.1142/S0192415X15500020
Compound Danshen (<i>Salvia miltiorrhiza</i>) Dripping Pill for Coronary Heart Disease: An Overview of Systematic Reviews
resolves10.1038/nrcardio.2017.65
Epidemiology of heart failure with preserved ejection fraction
resolves10.1161/CIRCULATIONAHA.118.037975
Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy
resolves10.1016/j.acvd.2016.10.004
COLIN trial: Value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response
resolves10.1016/j.pharmthera.2018.01.001
Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities
resolves10.1016/j.jcmg.2017.03.003
Myocardial Inflammation
resolves10.1161/CIRCRESAHA.116.302317
Innate Immunity and the Failing Heart
resolves10.1038/cddis.2016.140
The emerging role of Toll-like receptor 4 in myocardial inflammation
resolves10.1161/CIRCRESAHA.110.226936
The Emerging Role of Innate Immunity in the Heart and Vascular System
resolves10.1097/CCM.0b013e3181b77fe3
Risk of death and the efficacy of eritoran tetrasodium (E5564): Design considerations for clinical trials of anti-inflammatory agents in sepsis*
resolves10.1001/jama.2013.2194
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis
resolves10.1016/j.phymed.2018.04.027
Evaluations of the effect of HuangQi against heart failure based on comprehensive echocardiography index and metabonomics
resolves10.1155/2013/149363
Effect of<i>Crataegus</i>Usage in Cardiovascular Disease Prevention: An Evidence-Based Approach
resolves10.1155/2011/378907
Neuron Regeneration and Proliferation Effects of Danshen and Tanshinone IIA
resolves10.1016/j.jacc.2013.11.023
In Vivo Silencing of the Transcription Factor IRF5 Reprograms the Macrophage Phenotype and Improves Infarct Healing
resolves10.1007/s10753-017-0681-7
CD80 Regulates Th17 Cell Differentiation in Coxsackie Virus B3-Induced Acute Myocarditis
resolves10.1161/CIRCULATIONAHA.118.035047
IL (Interleukin)-10–STAT3–Galectin-3 Axis Is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction
resolves10.1093/cvr/cvt047
Extracellular HSP60 induces inflammation through activating and up-regulating TLRs in cardiomyocytes
resolves10.1371/journal.pone.0051243
A Critical Role for MAPK Signalling Pathways in the Transcriptional Regulation of Toll Like Receptors
resolves10.1161/CIRCRESAHA.113.301198
Enhanced Efferocytosis of Apoptotic Cardiomyocytes Through Myeloid-Epithelial-Reproductive Tyrosine Kinase Links Acute Inflammation Resolution to Cardiac Repair After Infarction
resolves10.1016/j.jacc.2016.05.011
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
The 2 references without a DOI — listed, not checked
no DOI — not checkedPathophysiology of Myocardial Infarction. Comprehensive
no DOI — not checkedDanshen: a phytochemical and pharmacological overview
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1111/jcmm.15688"><img src="https://citestamp.com/citestamped/10.1111/jcmm.15688/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1111/jcmm.15688/badge.svg)](https://citestamp.com/citestamped/10.1111/jcmm.15688)